Related Experiment Video
Updated: Jun 16, 2026
07:25
Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension
1Department of Biomedical Engineering, School of Medicine, Kyung Hee University, Seoul, Korea.
Journal of Human Hypertension
|February 12, 2010
Summary
This study identified five single-nucleotide polymorphisms (SNPs) associated with systolic blood pressure and hypertension risk in South Korean cohorts. Two specific SNPs, rs16835244 and rs2286672, were linked to increased hypertension risk, offering insights into genetic factors.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Genomic Epidemiology
Background:
- Hypertension is a major global health concern with complex genetic underpinnings.
- Genome-wide association studies (GWAS) are crucial for identifying genetic variants associated with complex diseases.
- Understanding the functional impact of non-synonymous single-nucleotide polymorphisms (SNPs) is key to elucidating disease mechanisms.
Purpose of the Study:
- To investigate the association of 1180 non-synonymous SNPs with systolic blood pressure (SBP) and hypertensive status.
- To identify specific SNPs that contribute to hypertension risk.
- To explore the biological relevance of identified SNPs through protein structure analysis.
Main Methods:
- Analysis of 1180 non-synonymous SNPs in 8842 individuals from two South Korean community-based cohorts (Ansung and Ansan).
- Statistical association analysis to determine the relationship between SNPs, SBP, and hypertensive status.
- In silico protein structure analysis to assess the functional impact of significant SNPs on protein conformation and function.
Main Results:
- Five SNPs (rs16835244, rs2286672, rs6265, rs17237198, rs7312017) showed significant association with SBP in both cohorts.
- SNPs rs16835244 and rs2286672 were correlated with an increased risk for hypertension.
- rs16835244 alters a conserved residue in arginine decarboxylase (ADC), potentially affecting protein conformation.
- rs2286672 affects a conserved residue in phospholipase D2 (PLD2) within the PX domain, important for membrane trafficking.
Conclusions:
- Non-synonymous SNPs rs16835244 and rs2286672 are associated with SBP and hypertension risk.
- The identified SNPs may contribute to hypertension development through alterations in protein structure and function.
- Integrating GWAS with biological relevance analysis, including protein structure, is a valuable approach for identifying hypertension-related genetic risk factors.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:30Alterations in Blood Pressure
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...